Pharmaceutical

FDA advisory committee reviews Novo Nordisk insulin ico...

The US FDA's EMDAC is set to hold a meeting to assess the benefit-risk profile o...

Grey Wolf gains $50m boost for antigen modulation tech

Grey Wolf Therapeutics has concluded an oversubscribed $50m in Series B financin...

Cystic fibrosis: global clinical trials landscape and t...

Affecting more than 162,000 patients worldwide, global clinical trials are resea...

EC approves Celltrion’s Omlyclo for allergic conditions

The EC has approved Celltrion’s Omlyclo, an omalizumab biosimilar for reference ...

Biocon and Handok link to commercialise Liraglutide in ...

Biocon has entered an exclusive licence and supply agreement with Handok to comm...

Magazine: Lula’s progress plan for Brazil: a year on

In this issue: Lula's progress plan for Brazil, tracking opioid lawsuit settleme...

ASCO 2024: MediLink’s NSCLC and breast cancer ADC shows...

The clinical-stage biotech will share preliminary safety and efficacy data with ...

AstraZeneca makes another obesity play funnelling $80m ...

AstraZeneca has the option to acquire SixPeaks in the next two years if the latt...

NICE recommends Rhythm’s Imcivree for rare genetic obes...

Rhythm expects Imcivree will be available on the NHS in England and Wales within...

No nitrosamines: How parenteral packaging is evolving t...

As the nitrosamine scandal continues, we explore the advancements in parenteral ...

How to take advantage of the connected health opportuni...

When new medicines hit the market, sharing educational content with physicians, ...

Genmab acquires biotechnology company ProfoundBio in $1...

Genmab has concluded the acquisition of ProfoundBio, a clinical-stage biotechnol...

Alvotech and Dr Reddy’s partner to commercialise AVT03

Alvotech has entered into a collaboration with Dr. Reddy's Laboratories for the ...

AltruBio secures $225m for immune checkpoint programme ...

AltruBio has secured $225m in an oversubscribed Series B financing round to prop...

Evotec shuts down gene therapy business in light of Q1 ...

Evotec will close an Austrian facility as it shuts down its gene therapy busines...

Process automation and equipment

Download our list of leading pharmaceutical process automation technologies to m...